Glaxo Wellcome Flonase
Executive Summary
Fluticasone propionate nasal spray approved Dec. 11 "for an additional indication for the treatment of nasal symptoms of perennial nonallergic rhinitis in adults and pediatric patients four years and older." The intranasal corticosteroid was previously approved for the treatment of allergic rhinitis